These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35869402)

  • 1. Outcomes of patients with acute Vogt-Koyanagi-Harada disease treated with intravenous corticosteroid pulse followed by the slow tapering of oral corticosteroid therapy.
    Fushitsu R; Ishibazawa A; Murono M; Kinouchi R
    Int Ophthalmol; 2023 Feb; 43(2):431-440. PubMed ID: 35869402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and visual outcomes of 111 patients with new-onset acute Vogt-Koyanagi-Harada disease treated with pulse intravenous corticosteroids.
    Nakayama M; Keino H; Watanabe T; Okada AA
    Br J Ophthalmol; 2019 Feb; 103(2):274-278. PubMed ID: 29666121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM; Dosari M; Hemachandran S; Gikandi PW; Al-Muammar A
    Acta Ophthalmol; 2017 Feb; 95(1):85-90. PubMed ID: 27535102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect on choroidal changes of the route of systemic corticosteroids in acute Vogt-Koyanagi-Harada disease.
    Park UC; Cho IH; Lee EK; Yu HG
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1203-1211. PubMed ID: 28382438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM; Hemachandran S; Al-Mezaine HS; Kangave D; Al-Muammar AM
    Acta Ophthalmol; 2012 Dec; 90(8):e603-8. PubMed ID: 22971163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High rate of clinical recurrence in patients with Vogt-Koyanagi-Harada disease treated with early high-dose corticosteroids.
    Sakata VM; da Silva FT; Hirata CE; Marin ML; Rodrigues H; Kalil J; Costa RA; Yamamoto JH
    Graefes Arch Clin Exp Ophthalmol; 2015 May; 253(5):785-90. PubMed ID: 25592477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute phase clinical manifestations of patients with Vogt-Koyanagi-Harada disease in Southern China.
    Zhang C; Wang Y; Chen Y; Zhou H; Hong Q; Yu X; Ng TK; Cen LP
    BMC Ophthalmol; 2023 May; 23(1):199. PubMed ID: 37147563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of probable Vogt-Koyanagi-Harada disease in a 3-year-old girl.
    Katsuyama A; Kusuhara S; Awano H; Nagase H; Matsumiya W; Nakamura M
    BMC Ophthalmol; 2019 Aug; 19(1):179. PubMed ID: 31409322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indocyanine green angiography in Vogt-Koyanagi-Harada disease: angiographic signs and utility in patient follow-up.
    Herbort CP; Mantovani A; Bouchenaki N
    Int Ophthalmol; 2007; 27(2-3):173-82. PubMed ID: 17457515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on corticosteroid therapy in Vogt-Koyanagi-Harada disease.
    Sasamoto Y; Ohno S; Matsuda H
    Ophthalmologica; 1990; 201(3):162-7. PubMed ID: 2089358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of combination therapy of prednisolone and cyclosporine with corticosteroid pulse therapy in Vogt-Koyanagi-Harada disease.
    Ono T; Goto H; Sakai T; Nitta F; Mizuki N; Takase H; Kaneko Y; Hori J; Nakano S; Nao-I N; Ohguro N; Miyata K; Tomita M; Mochizuki M;
    Jpn J Ophthalmol; 2022 Mar; 66(2):119-129. PubMed ID: 34689288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of early cerebrospinal fluid-guided diagnosis and early high-dose corticosteroid therapy on ocular outcomes of Vogt-Koyanagi-Harada disease.
    Miyanaga M; Kawaguchi T; Shimizu K; Miyata K; Mochizuki M
    Int Ophthalmol; 2007; 27(2-3):183-8. PubMed ID: 17476572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors and adalimumab efficacy in managing chronic recurrence Vogt-Koyanagi-Harada disease.
    Feng H; Chen W; Yang J; Kong H; Li H; He Y; Wang H
    BMC Ophthalmol; 2024 Jun; 24(1):238. PubMed ID: 38849758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease.
    Lai TY; Chan RP; Chan CK; Lam DS
    Eye (Lond); 2009 Mar; 23(3):543-8. PubMed ID: 18369377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Outcomes of Patients with Vogt-Koyanagi-Harada Disease Over 12 Years at a Tertiary Center.
    Arevalo JF; Lasave AF; Gupta V; Kozak I; Al Harbi MB; Al Rushood AA; Al Dhibi HA
    Ocul Immunol Inflamm; 2016 Oct; 24(5):521-9. PubMed ID: 26399962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease occurred during pregnancy.
    Alromaih AZ; Almater AI; Albloushi AF; Alkheraiji NF; Abu El-Asrar AM
    Int Ophthalmol; 2023 Jan; 43(1):185-195. PubMed ID: 35945413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivation of previously controlled Vogt-Koyanagi-Harada disease more than 46 years following COVID-19 vaccination: a case study.
    Muto T; Sakamoto M; Imaizumi S; Kamoi K
    J Int Med Res; 2024 Jan; 52(1):3000605231221081. PubMed ID: 38170955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of pulse corticosteroid therapy for vogt-koyanagi-harada disease assessed by optical coherence tomography.
    Yamanaka E; Ohguro N; Yamamoto S; Nakagawa Y; Imoto Y; Tano Y
    Am J Ophthalmol; 2002 Sep; 134(3):454-6. PubMed ID: 12208266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Outcomes of Limited Vogt-Koyanagi-Harada Syndrome.
    Chew SK; Levy J; Rogers S; Lim LL
    Am J Ophthalmol; 2016 Jul; 167():52-6. PubMed ID: 27066721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic corticosteroid treatment in Vogt-Koyanagi-Harada disease.
    Hayasaka S; Okabe H; Takahashi J
    Graefes Arch Clin Exp Ophthalmol; 1982; 218(1):9-13. PubMed ID: 7056483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.